FDA approves 9 generic versions of nerve pain drug Lyrica

The U.S. Food and Drug Administration has approved the first generic copies of a popular, pricey pill for nerve pain.

The agency on Monday said it approved nine generic versions of Pfizer Inc.'s Lyrica. It is also used for seizures and fibromyalgia, a condition that causes chronic, widespread pain.

Lyrica, approved in 2004, is Pfizer's second bestseller, with sales last year of $4.6 billion. The heavily advertised drug costs about $460 to $720 per month without insurance, depending on the pharmacy. Prices can vary widely.

Prices for generic versions range from about $140 to $370 per month, according to the drug price comparison site GoodRx .

Common side effects include dizziness, blurred vision and sleepiness. Serious side effects include and life-threatening breathing problems.


Explore further

FDA approves first generic versions of Cymbalta

© 2019 The Associated Press. All rights reserved.

Citation: FDA approves 9 generic versions of nerve pain drug Lyrica (2019, July 22) retrieved 21 August 2019 from https://medicalxpress.com/news/2019-07-fda-versions-nerve-pain-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more